Structured Documentation in Cannabinoid Prescribing

Consistent records of product, batch, and patient-reported outcomes make clinical experience easier to review and share.

Clinical Context

Where cannabinoid medicines are prescribed, documentation practices vary widely. Inconsistent records make it difficult to review outcomes or report adverse events reliably.

What to Record

Product name, batch number, cannabinoid content, route of administration, and the dates of any changes form a minimal dataset that supports pharmacovigilance.

Applying It in Clinic

Simple templates in the clinical record reduce variability between clinicians and make follow-up visits more efficient.

Bottom Line

Batch-level traceability from the supplier is only useful if it is captured at the point of care. Good records close the loop.